This effect may be mediated through central neural pathways as has been established for the action of GLP-1 to inhibit gastric acid secretion (52)
They also enhance the cardiac mitochondrial function leading to improved outcomes under hypoxic conditions and reduced pathologic remodeling [31]
Sources National Institutes of Health, National Library of Medicine, ClinicalTrials.gov Registry entries and study protocols for triple agonist metabolic compounds under investigation
But their effects on the body have turned out to be broader than anyone expected, and the list of approved uses keeps growing Heart disease
Anecdotal reports suggest potentially stronger effects, but without controlled comparisons, this remains speculative
Tesamorelin / Ipamorelin (Growth Hormone Fat Loss Stack) The Growth Hormone Fat Loss Stack combines Tesamorelin and Ipamorelin, two highly effective peptides known for their ability to significantly enhance growth hormone (GH) secretion and target fat loss, particularly visceral fat